Experimental Gene Therapy Improves Sight Among Patients With Blindness Condition Choroideremia
He stressed that the therapy is still in the experimental stage, with more trials likely to take up to five years before
experimental gene therapy improve sight patient blindness condition choroideremia stress therapy experimental stage trial likely year